Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.
IV 期上市后监测研究表明，Stempeucel 对因布尔格氏病引起的严重肢体缺血患者持续有效且安全
期刊:Stem Cells Translational Medicine
影响因子:4.9
doi:10.1002/sctm.21-0197
Gupta Pawan Kumar, Dutta Santanu, Kala Sanjay, Nekkanti Muralikrishna, Desai Sanjay C, Mahapatra Subhendu S, Dhar Anita, Raju Radhakrishnan, M Rajkumar, Behera Arunanshu, P Shivashankar, Raviraja N S, Viswanathan Pachaiyappan, Chandrashekar Mithun, Thej Charan, K V Prasanth, Abraham Jijy, Boggarapu Hema, Udaykumar K
